Author

Yu-Han Wu

National Taiwan University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:simulation· 1 Approach:statistical model· 1 Assay:structural biology· 1

Frequent Co-Authors

Ahmed Mohamed RagabiD· 1 shared Christopher Llynard D. OrtiziD· 1 shared Jian-Zhou Wang· 1 shared Jin‐Der WeniD· 1 shared Lee‐Wei YangiD· 1 shared Yi-Jen HuangiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Ahmed Mohamed RagabORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Drug Functional Site-Unknown Molecular Targets Exemplified by SARS-CoV-2 pseudoknot and ribosomal frameshifting-modulators

Ahmed Mohamed Ragab, Christopher Llynard D. Ortiz, Yi-Jen Huang, Jian-Zhou Wang, Yu-Han Wu, Jin‐Der Wen, Lee‐Wei Yang

This paper identifies FDA-approved drugs that modulate SARS-CoV-2 -1 PRF by altering RNA pseudoknot folding dynamics, demonstrating a strategy for targeting structured RNAs.

bioRxiv · Jul 3, 2026 · PreprintBiochemistry